Variant report

Variant	nsv1059633
Chromosome Location	chr16:30803099-30867916
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:2078)
CpG islands
(count:2198)
Chromatin interactive
region (count:174)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:2078 , 50 per page) page: 1 2 3 4 5 6 7 ... 42

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:30820079-30820420	K562	blood:	n/a	n/a
2	ARID3A	chr16:30835464-30835889	HepG2	liver:	n/a	n/a
3	ARID3A	chr16:30820559-30820850	HepG2	liver:	n/a	n/a
4	ARID3A	chr16:30850151-30850722	HepG2	liver:	n/a	n/a
5	ARID3A	chr16:30816769-30817147	HepG2	liver:	n/a	n/a
6	ARID3A	chr16:30817395-30817553	K562	blood:	n/a	n/a
7	ARID3A	chr16:30841457-30841712	HepG2	liver:	n/a	n/a
8	ARID3A	chr16:30816731-30817048	K562	blood:	n/a	n/a
9	ARID3A	chr16:30855788-30856350	K562	blood:	n/a	n/a
10	ARID3A	chr16:30855777-30856384	HepG2	liver:	n/a	n/a
11	ARID3A	chr16:30825277-30826011	HepG2	liver:	n/a	n/a
12	ATF1	chr16:30820124-30820406	K562	blood:	n/a	n/a
13	ATF1	chr16:30825652-30826074	K562	blood:	n/a	n/a
14	ATF1	chr16:30849404-30849590	K562	blood:	n/a	n/a
15	ATF1	chr16:30855931-30856478	K562	blood:	n/a	n/a
16	ATF2	chr16:30816623-30817041	H1-hESC	embryonic stem cell:	n/a	n/a
17	ATF2	chr16:30825415-30825950	GM12878	blood:	n/a	n/a
18	ATF2	chr16:30825566-30825877	H1-hESC	embryonic stem cell:	n/a	n/a
19	ATF2	chr16:30825451-30825823	H1-hESC	embryonic stem cell:	n/a	n/a
20	ATF3	chr16:30825568-30825867	K562	blood:	n/a	chr16:30825674-30825694
21	ATF3	chr16:30816700-30817180	A549	lung:	n/a	n/a
22	ATF3	chr16:30855969-30856319	K562	blood:	n/a	n/a
23	ATF3	chr16:30816624-30817151	A549	lung:	n/a	n/a
24	ATF3	chr16:30825521-30826127	K562	blood:	n/a	chr16:30825674-30825694 chr16:30825954-30825974 chr16:30825965-30825985
25	BACH1	chr16:30825469-30826024	H1-hESC	embryonic stem cell:	n/a	n/a
26	BACH1	chr16:30816736-30816936	H1-hESC	embryonic stem cell:	n/a	n/a
27	BCL3	chr16:30816527-30817169	A549	lung:	n/a	chr16:30817071-30817080 chr16:30816929-30816938 chr16:30816895-30816904
28	BCL3	chr16:30825488-30826079	A549	lung:	n/a	chr16:30825795-30825808
29	BCL3	chr16:30825359-30825912	A549	lung:	n/a	chr16:30825795-30825808
30	BCL3	chr16:30816603-30817241	A549	lung:	n/a	chr16:30817071-30817080 chr16:30816929-30816938 chr16:30816895-30816904
31	BCLAF1	chr16:30855946-30856439	GM12878	blood:	n/a	n/a
32	BCLAF1	chr16:30816598-30817139	K562	blood:	n/a	chr16:30817071-30817080 chr16:30816929-30816938 chr16:30816895-30816904
33	BCLAF1	chr16:30825494-30826110	GM12878	blood:	n/a	chr16:30825795-30825808
34	BCLAF1	chr16:30816704-30817035	GM12878	blood:	n/a	chr16:30816929-30816938 chr16:30816895-30816904
35	BCLAF1	chr16:30856009-30856351	GM12878	blood:	n/a	n/a
36	BHLHE40	chr16:30816743-30817003	GM12878	blood:	n/a	n/a
37	BHLHE40	chr16:30855916-30856355	K562	blood:	n/a	n/a
38	BHLHE40	chr16:30825546-30825865	A549	lung:	n/a	chr16:30825759-30825775
39	BHLHE40	chr16:30817448-30817462	GM12878	blood:	n/a	n/a
40	BHLHE40	chr16:30820174-30820342	K562	blood:	n/a	n/a
41	BHLHE40	chr16:30825397-30826055	HepG2	liver:	n/a	chr16:30825759-30825775
42	BHLHE40	chr16:30856030-30856353	HepG2	liver:	n/a	n/a
43	BHLHE40	chr16:30820594-30820833	HepG2	liver:	n/a	n/a
44	BHLHE40	chr16:30825393-30825758	HepG2	liver:	n/a	n/a
45	BHLHE40	chr16:30825415-30826062	K562	blood:	n/a	chr16:30825759-30825775
46	BHLHE40	chr16:30816677-30817516	K562	blood:	n/a	n/a
47	BHLHE40	chr16:30825443-30825912	GM12878	blood:	n/a	chr16:30825759-30825775
48	BRCA1	chr16:30856168-30856371	GM12878	blood:	n/a	n/a
49	BRCA1	chr16:30816799-30816877	H1-hESC	embryonic stem cell:	n/a	n/a
50	BRCA1	chr16:30856020-30856583	HepG2	liver:	n/a	n/a

(count:2198 , 50 per page) page: 1 2 3 4 5 6 7 ... 44

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:30829666-30829716	HIPEpiC	eye:	n/a
2	chr16:30856600-30856650	Caco-2	colon:	n/a
3	chr16:30829666-30829716	HIPEpiC	eye:	n/a
4	chr16:30856600-30856650	Caco-2	colon:	n/a
5	chr16:30817051-30817101	GM12878	blood:	n/a
6	chr16:30817051-30817101	GM12891	blood:	n/a
7	chr16:30845818-30845868	HCPEpiC	choroid plexus:	n/a
8	chr16:30829666-30829716	HMEC	breast:	n/a
9	chr16:30820353-30820403	HCPEpiC	choroid plexus:	n/a
10	chr16:30835298-30835348	HAEpiC	amniotic membrane:	n/a
11	chr16:30835298-30835348	NB4	blood:	n/a
12	chr16:30833292-30833342	U87	brain:	n/a
13	chr16:30832529-30832579	HPAEpiC	pulmonary alveolar:	n/a
14	chr16:30832794-30832844	Hela-S3	cervix:	n/a
15	chr16:30845959-30846009	U87	brain:	n/a
16	chr16:30846150-30846200	AG09319	gingival:	n/a
17	chr16:30832529-30832579	IMR90	lung:	fetal
18	chr16:30825646-30825696	HRE	kidney:	n/a
19	chr16:30832346-30832396	HNPCEpiC	eye:	n/a
20	chr16:30835298-30835348	A549	lung:	n/a
21	chr16:30825646-30825696	BE2_C	brain:	n/a
22	chr16:30825733-30825783	SK-N-SH_RA	brain:	n/a
23	chr16:30845201-30845251	MCF10A-Er-Src	breast:	n/a
24	chr16:30846150-30846200	NT2-D1	testis:	n/a
25	chr16:30841666-30841716	IMR90	lung:	fetal
26	chr16:30833381-30833431	AG09319	gingival:	n/a
27	chr16:30833292-30833342	H1-hESC	embryonic stem cell:	embryo
28	chr16:30841666-30841716	BJ	skin:	n/a
29	chr16:30845959-30846009	AG10803	skin:	n/a
30	chr16:30825733-30825783	NB4	blood:	n/a
31	chr16:30817779-30817829	NHDF-neo	bronchial:	n/a
32	chr16:30845201-30845251	K562	blood:	n/a
33	chr16:30825529-30825579	SAEC	small airway:	n/a
34	chr16:30813600-30813650	NB4	blood:	n/a
35	chr16:30832385-30832435	GM06990	blood:	n/a
36	chr16:30830748-30830798	PFSK-1	brain:	n/a
37	chr16:30832794-30832844	NT2-D1	testis:	n/a
38	chr16:30848968-30849018	GM12891	blood:	n/a
39	chr16:30817779-30817829	AG04449	skin:	fetal
40	chr16:30813600-30813650	ECC-1	luminal epithelium:	n/a
41	chr16:30817168-30817218	HepG2	liver:	n/a
42	chr16:30832385-30832435	HRPEpiC	eye:	n/a
43	chr16:30816924-30816974	SAEC	small airway:	n/a
44	chr16:30817779-30817829	AG10803	skin:	n/a
45	chr16:30853476-30853526	HNPCEpiC	eye:	n/a
46	chr16:30825646-30825696	SK-N-MC	brain:	n/a
47	chr16:30823315-30823365	AG10803	skin:	n/a
48	chr16:30845201-30845251	A549	lung:	n/a
49	chr16:30817168-30817218	T-47D	breast:	n/a
50	chr16:30817168-30817218	AG04449	skin:	fetal

(count:174 , 50 per page) page: 1 2 3 4

No.	Distal block	Cell Line	Cell type
1	chr16:30843974..30846904-chr16:30847751..30850553,2	K562	blood:
2	chr16:30866277..30869586-chr16:30933014..30934701,3	MCF-7	breast:
3	chr16:30864812..30866480-chr16:30884926..30886769,2	MCF-7	breast:
4	chr16:30803049..30805993-chr16:30806956..30809865,3	MCF-7	breast:
5	chr16:30825727..30827362-chr16:30915588..30917654,2	MCF-7	breast:
6	chr16:30795066..30800356-chr16:30815303..30822232,38	MCF-7	breast:
7	chr16:30803684..30806177-chr16:30912037..30915319,3	MCF-7	breast:
8	chr16:30815583..30820055-chr16:30823103..30827035,12	MCF-7	breast:
9	chr16:30816360..30819026-chr16:30906780..30909255,2	K562	blood:
10	chr16:30797419..30799441-chr16:30855931..30858040,2	MCF-7	breast:
11	chr16:30825905..30827673-chr16:30830413..30833381,3	MCF-7	breast:
12	chr16:30796949..30800818-chr16:30804737..30809387,9	MCF-7	breast:
13	chr16:30816905..30818572-chr16:30853615..30856122,3	MCF-7	breast:
14	chr16:30786387..30788885-chr16:30817095..30819249,4	K562	blood:
15	chr16:30817154..30820874-chr16:30824178..30827493,4	K562	blood:
16	chr16:30815388..30818380-chr16:30912110..30914364,3	MCF-7	breast:
17	chr16:30797708..30801530-chr16:30815356..30818567,4	K562	blood:
18	chr16:30824453..30827100-chr16:30934941..30936872,2	MCF-7	breast:
19	chr16:30802488..30809152-chr16:30815152..30818622,8	MCF-7	breast:
20	chr16:30856150..30858007-chr16:30885363..30888361,3	MCF-7	breast:
21	chr16:30831137..30833191-chr16:30833927..30836731,2	MCF-7	breast:
22	chr16:30856121..30856695-chr16:30905519..30906109,2	MCF-7	breast:
23	chr16:30855963..30857939-chr16:30858121..30859686,2	MCF-7	breast:
24	chr16:30854666..30857562-chr16:30907010..30909782,3	K562	blood:
25	chr16:30840609..30843295-chr16:30848327..30849905,2	K562	blood:
26	chr16:30855664..30857154-chr16:30912896..30914067,10	K562	blood:
27	chr16:30823017..30826928-chr16:30884539..30888013,5	MCF-7	breast:
28	chr16:30866357..30873992-chr16:30883788..30889320,16	MCF-7	breast:
29	chr16:30835263..30837258-chr16:30846871..30849044,2	K562	blood:
30	chr16:30815766..30818502-chr16:30968235..30970702,3	MCF-7	breast:
31	chr16:30856938..30859653-chr16:30877625..30880154,2	K562	blood:
32	chr16:30786896..30788399-chr16:30817095..30819467,2	K562	blood:
33	chr16:30797148..30800499-chr16:30815356..30818471,7	K562	blood:
34	chr16:30787386..30789402-chr16:30849116..30851160,2	MCF-7	breast:
35	chr16:30838352..30840109-chr16:30843617..30845692,2	K562	blood:
36	chr16:30816836..30817369-chr16:30886785..30887523,3	Hela-S3	cervix:
37	chr16:30771133..30773580-chr16:30817953..30819677,2	K562	blood:
38	chr16:30855497..30856657-chr16:30932633..30933761,9	MCF-7	breast:
39	chr1:156110778..156111480-chr16:30816724..30817309,2	Hela-S3	cervix:
40	chr16:30838714..30840881-chr16:30843458..30846272,2	MCF-7	breast:
41	chr16:30815220..30818805-chr16:30903987..30908642,7	MCF-7	breast:
42	chr16:30858161..30859843-chr16:30884895..30886672,2	MCF-7	breast:
43	chr16:30852383..30857550-chr16:30903226..30907959,5	MCF-7	breast:
44	chr16:30797714..30799232-chr16:30811739..30813983,2	K562	blood:
45	chr16:30843974..30846904-chr16:30847751..30850553,2	K562	blood:
46	chr16:30786955..30788524-chr16:30856024..30857941,2	MCF-7	breast:
47	chr16:30816616..30817453-chr9:74980073..74981044,2	HCT-116	colon:
48	chr16:30837941..30839852-chr16:30843371..30845692,2	K562	blood:
49	chr16:30855721..30856595-chr16:30932675..30933477,5	MCF-7	breast:
50	chr16:30817154..30820688-chr16:30821822..30825737,4	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RNF40-3	chr16:30842887-30843320	expReg_chr16_4640_+

No data

Variant related genes	Relation type
ZNF629	TF binding region
BCL7C	TF binding region
ENSG00000260082	TF binding region
ZNF629	CpG island
BCL7C	CpG island
ENSG00000260082	CpG island
ENSG00000211591	chromatin interactions
ENSG00000196118	chromatin interactions
ENSG00000169957	chromatin interactions
ENSG00000099381	chromatin interactions
ENSG00000129282	chromatin interactions
ENSG00000150281	chromatin interactions
ENSG00000265991	chromatin interactions
ENSG00000262026	chromatin interactions
ENSG00000156858	chromatin interactions
ENSG00000260852	chromatin interactions
ENSG00000107372	chromatin interactions
ENSG00000103510	chromatin interactions
ENSG00000099364	chromatin interactions
ENSG00000103549	chromatin interactions
ENSG00000203865	chromatin interactions
ENSG00000080603	chromatin interactions
ENSG00000262766	chromatin interactions
ENSG00000251562	chromatin interactions
ENSG00000099385	chromatin interactions
ENSG00000156873	chromatin interactions
ENSG00000102870	chromatin interactions
ENSG00000260083	chromatin interactions
ENSG00000262721	chromatin interactions
ENSG00000261840	chromatin interactions
ENSG00000165644	chromatin interactions

Extended variants
information (count: 2105 )
Associated
traits (count: 121 )

Variant overlapped rSNPs/rCNVs (count:2105 , 50 per page) page: 1 2 3 4 5 6 7 ... 43

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs577649519	chr16:30803099-30803100	Weak transcription Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs535762758	chr16:30803173-30803174	Weak transcription Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs138839388	chr16:30803240-30803241	Weak transcription Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs11645175	chr16:30803299-30803300	Weak transcription Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs575262464	chr16:30803303-30803304	Weak transcription Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs376250745	chr16:30803321-30803322	Weak transcription Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs542951751	chr16:30803322-30803323	Weak transcription Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs185859310	chr16:30803434-30803435	Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs116754394	chr16:30803483-30803484	Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs540407341	chr16:30803525-30803526	Weak transcription Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs370357709	chr16:30803538-30803539	Weak transcription Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs564897989	chr16:30803546-30803547	Weak transcription Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs190663629	chr16:30803581-30803582	Weak transcription Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs539481341	chr16:30803583-30803584	Weak transcription Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs372939527	chr16:30803595-30803596	Weak transcription Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs532663387	chr16:30803603-30803604	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs550754545	chr16:30803622-30803623	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs557733212	chr16:30803633-30803634	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs568922674	chr16:30803642-30803643	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs141945728	chr16:30803652-30803653	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs181761175	chr16:30803697-30803698	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs567783991	chr16:30803721-30803722	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs145616267	chr16:30803730-30803731	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs566475723	chr16:30803735-30803736	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs534160469	chr16:30803792-30803793	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs559118976	chr16:30803817-30803818	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs570929297	chr16:30803822-30803823	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs538730685	chr16:30803823-30803824	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs373957551	chr16:30803834-30803835	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs557052550	chr16:30803849-30803850	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs575351103	chr16:30803850-30803851	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs377535639	chr16:30803851-30803852	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs542624618	chr16:30803903-30803904	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs187207203	chr16:30803908-30803909	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs573108079	chr16:30803951-30803952	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs533872974	chr16:30804003-30804004	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs12232385	chr16:30804014-30804015	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs62057224	chr16:30804053-30804054	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs565095713	chr16:30804065-30804066	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs62057225	chr16:30804069-30804070	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs374619846	chr16:30804145-30804146	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs138479850	chr16:30804158-30804159	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs532170263	chr16:30804197-30804198	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs544342437	chr16:30804236-30804237	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs12447534	chr16:30804257-30804258	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
46	rs75513610	chr16:30804380-30804381	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs192041934	chr16:30804392-30804393	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs566716413	chr16:30804394-30804395	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs182687467	chr16:30804428-30804429	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs574151486	chr16:30804467-30804468	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:121)

Disease	PMID	Source
Hodgkin''s lymphoma	20651079	CNVD
Metanephric adenoma	20802469	CNVD
Melanoma	18172304	CNVD
Breast cancer	16608533	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Autism	22566537	CNVD
Intellectual disability	22566537	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Lung cancer	18438408	CNVD
Ductal carcinoma	22052326	CNVD
Breast cancer	21509527	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Mental retardation	19951919	CNVD
Colorectal cancer	16272173	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Bladder cancer	21909424	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21785460	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21990379	CNVD
Astrocytoma	22246337	CNVD
Myelofibrosis	22110671	CNVD
Epilepsy	22499536	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22513405	CNVD
Autism	22958593	CNVD
Autism	18184952	CNVD
Autism	19966786	CNVD
Autism	21394203	CNVD
Autism	21969575	CNVD
Autism	22241247	CNVD
Autism	20970697	CNVD
Autism	20942916	CNVD
Epilepsy	20970697	CNVD
Intellectual disability	22045946	CNVD
Mental retardation	19966786	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Autism	18923514	CNVD
Obesity	21881559	CNVD
Obesity	21956041	CNVD
Autism	20659124	CNVD
Mental retardation	21062444	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	21285140	CNVD
Schizophrenia	22885689	CNVD
Schizophrenia	20553308	CNVD
Schizophrenia	20970697	CNVD
Schizophrenia	20433910	CNVD
Schizophrenia	22241247	CNVD
Autism	19242545	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Intracranial ependymoma	16609018	CNVD
Schizophrenia	21399695	CNVD
Autism	21956041	CNVD
Disorders of sex development	21048976	CNVD
Autism	22067053	CNVD
Autism	18156158	CNVD
Mental retardation	20152051	CNVD
Autism	19218893	CNVD
Autism	21289514	CNVD
Schizophrenia	19855392	CNVD
neurodevelopmental Syndrome	20503337	CNVD
Benign familial neonatal-infantile seizures	21060786	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Cancer	21183584	CNVD
Low-grade fibromyxoid sarcoma	21536545	CNVD
Breast cancer	21045282	CNVD
Neuroblastoma	20406844	CNVD
Autism	19050728	CNVD
Epilepsy	20923578	CNVD
Psychiatric disorder	19050728	CNVD
Schizophrenia	19348701	CNVD
Attention deficit hyperactivity disorder	19097825	CNVD
Autism	20964600	CNVD
Schizophrenia	19955444	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	19571808	CNVD
Breast cancer	20409316	CNVD
Severe combined immunodeficiency	19097825	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Autism	18522746	CNVD
Urothelial carcinoma	21177765	CNVD
Chronic myeloid leukemia	21384125	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Autism	19492091	CNVD

Chromatin state (count:1670 , 50 per page) page: 1 2 3 4 5 6 7 ... 34

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:30799600-30803400	Weak transcription	Pancreas	Pancrea
2	chr16:30799600-30805000	Weak transcription	Right Ventricle	heart
3	chr16:30799800-30804600	Weak transcription	Primary B cells from cord blood	blood
4	chr16:30800000-30804200	Weak transcription	Spleen	Spleen
5	chr16:30800200-30816200	Weak transcription	Fetal Intestine Small	intestine
6	chr16:30803000-30803600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
7	chr16:30803200-30803400	Bivalent Enhancer	HepG2	liver
8	chr16:30804000-30805200	Bivalent Enhancer	HepG2	liver
9	chr16:30804800-30805200	Enhancers	K562	blood
10	chr16:30805200-30805400	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr16:30805200-30805600	Flanking Bivalent TSS/Enh	HepG2	liver
12	chr16:30805200-30806200	Weak transcription	K562	blood
13	chr16:30805600-30806400	Enhancers	HepG2	liver
14	chr16:30806000-30806200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
15	chr16:30806200-30806400	Enhancers	K562	blood
16	chr16:30806400-30808200	Weak transcription	HepG2	liver
17	chr16:30807600-30809600	Enhancers	Hela-S3	cervix
18	chr16:30808000-30808600	Enhancers	Skeletal Muscle Male	skeletal muscle
19	chr16:30808200-30808600	Enhancers	Muscle Satellite Cultured Cells	--
20	chr16:30808200-30808600	Enhancers	A549	lung
21	chr16:30808200-30808800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
22	chr16:30808200-30808800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
23	chr16:30808200-30809800	Enhancers	HepG2	liver
24	chr16:30808400-30816400	Weak transcription	Brain Hippocampus Middle	brain
25	chr16:30808600-30816200	Weak transcription	Skeletal Muscle Male	skeletal muscle
26	chr16:30809400-30809600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr16:30809600-30816400	Weak transcription	Hela-S3	cervix
28	chr16:30809800-30811200	Weak transcription	HepG2	liver
29	chr16:30810400-30816200	Weak transcription	Primary neutrophils fromperipheralblood	blood
30	chr16:30811200-30811600	Enhancers	HepG2	liver
31	chr16:30811600-30813800	Weak transcription	HepG2	liver
32	chr16:30813800-30814600	Flanking Active TSS	HepG2	liver
33	chr16:30813800-30815000	Enhancers	Fetal Thymus	thymus
34	chr16:30814000-30814200	Enhancers	Adipose Nuclei	Adipose
35	chr16:30814000-30814400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr16:30814000-30814400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
37	chr16:30814000-30814400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
38	chr16:30814000-30814800	Enhancers	Monocytes-CD14+_RO01746	blood
39	chr16:30814000-30815000	Enhancers	Primary monocytes fromperipheralblood	blood
40	chr16:30814000-30815000	Enhancers	Primary hematopoietic stem cells short term culture	blood
41	chr16:30814200-30814400	Enhancers	Primary T cells from cord blood	blood
42	chr16:30814200-30814400	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr16:30814200-30816400	Weak transcription	Adipose Nuclei	Adipose
44	chr16:30814400-30814600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
45	chr16:30814400-30814800	Enhancers	Cortex derived primary cultured neurospheres	brain
46	chr16:30814400-30814800	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
47	chr16:30814400-30816200	Weak transcription	Primary T cells from cord blood	blood
48	chr16:30814400-30816400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
49	chr16:30814400-30816400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
50	chr16:30814400-30816400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links